Sign in for the best experience.
Lung cancer remains the number one cause of cancer death in men and women in the United States and much of the world. This guideline examines the literature on primary treatment of patients with stage I and II non-small cell lung cancer (NSCLC) and consists of 17 evidence-based recommendations that clinicians can implement in their practice.
ACCESS THE FULL GUIDELINE
In patients with clinical stage I NSCLC, we recommend minimally invasive approaches over thoracotomy.
In medically fit patients with clinical stage I NSCLC tumors that are centrally located or > 2 cm, we recommend lobectomy over sublobar resection.
In medically fit patients with clinical stage II NSCLC, we recommend lobectomy over sublobar resection.
For patients with completely resected stage II NSCLC, we recommend treatment with adjuvated chemotherapy.
Advertisement
CHEST Releases Guideline on Management of Early-Stage Non-Small Cell Lung Cancer In a release issued to the media, lead author John Howington, MD, MBA, FCCP, speaks to the importance of this guideline in practice.
CHEST offers education, networking opportunities, and articles on interventional pulmonary topics.
This Network advances clinical practice in the areas of interventional procedures, lung cancer, pleural disease, and ultrasound/chest imaging.
Improve your expertise in lung cancer diagnosis and management, and claim up to 33.5 hours of credit—all in one place, via web and mobile device.
Sign up for expert-led, hands-on simulation courses offering training in diagnostic bronchoscopy, pleural procedures, and more.